Pasanting, Jene Rose .

HRN: 28-18-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2025
CEFUROXIME 500MG (TAB)
11/28/2025
12/05/2025
ORAL
500 Mg
Bid
S/p Nsvd With Rmle
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines